Across TCGA pan-cancer cohorts, RNA5SP355 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP355’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where RNA5SP355 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP355 is over-expressed in tumor.
COAD and STAD are the cancer types where RNA5SP355 tumor–normal differential expression is most reproducible.